Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Versant Futures

- PMLiVE

Pharma sales help Bayer escape the worst from a bumpy 2017

But the German pharma firm reins in expectations for this year

Working with our healthcare system more closely is vital

Bayer’s Lars Bruening on partnership working amid environmental challenges

- PMLiVE

Adopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

Novartis day

Novartis’ Extavia evades NICE restrictions on MS drugs

But Avonex, Plegridy, Betaferon, Rebif and Copaxone are set to be turned down

Bayer symbol

Bayer gets clinical data to support $1.5bn Loxo deal

Larotrectinib’s response rate likely to be practice changing

Bayer symbol

Joerg Moeller to head Bayer R&D after operational shake-up

Andreas Busch to move to Shire as head of R&D and CSO

Perspective on biotech leaders

In the latest issue of Perspective magazine, seven industry trailblazers reveal the trends, challenges and opportunities they anticipate in the biotech sector, from empowering patients to deciphering big data.

Blue Latitude Health

Danish biotech establishes online scientific collaboration network

Novozymes hopes to help tackle major health problems through HelloScience

- PMLiVE

Regeneron and Bayer drop AMD combination

Abandon plans after disappointing phase II trial results

Bayer symbol

Bayer drug-device combo for pneumonia flunks phase III test

NKTR-061 failed to provide additional benefit over standard antibiotic treatment

- PMLiVE

Bayer picks up PMEA award for multi-channel engagement

Close-run category sees its iMCM Lighthouse Project triumph

- PMLiVE

Loxo’s cancer drug pair attracts $1.5bn deal with Bayer

The German pharma group will gain full rights to the drugs outside the US

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links